1 of 3 listed pharmas with SG&A ration higher than 40%
1 of 3 listed pharmaceutical companies reportedly have a SG&A expense/sales ratio higher than 40%.
Yakup Shinmoon(www.yakup.com) analyzed 2018 1st quarter business performances that 62 listed pharmaceutical companies recorded, and the analysis showed that they recorded a 28.4% ratio of SG&A(sell...
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.